markets Gland Pharma shares: Proven insights on market rally potential Russell ClarksonNovember 9, 20260 Gland Pharma shares are hitting a 52-week high; explore if the rally will continue after a significant YTD rise.
markets Ashok Leyland shares: A Proven Boost in Stock Value Russell ClarksonNovember 5, 20260 Ashok Leyland shares jumped over 10% recently, marking a significant gain. Discover what factors contributed to this surge.
IPO News Zetwerk Manufacturing share price: Smart listing at 5% premium Russell ClarksonOctober 23, 20260 Zetwerk Manufacturing share price has listed at a 5% premium on BSE and NSE, reflecting strong market interest and confidence.
ipo Prasol Chemicals IPO Shows Worst Discount with Proven Demand Russell ClarksonSeptember 18, 20260 Prasol Chemicals IPO opens at a 9.76% discount despite 3.47x subscription, raising investor concerns.
markets Purple Style Labs stock: Worst debut with 7% discount Russell ClarksonSeptember 9, 20260 Purple Style Labs stock faces a weak debut, opening at a 7% discount on NSE.